Holzer Holzer & Fistel, LLC Announces Investigation Into Sequenom, Inc.
ATLANTA, April 30, 2009 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating possible violations of federal securities law by Sequenom, Inc. ("Sequenom" or the "Company") (Nasdaq:SQNM). The investigation focuses on, among other things, whether Sequenom violated the Securities Exchange Act of 1934 by issuing materially false and misleading statements regarding the Company's Down syndrome test under development. Specifically, the investigation seeks to determine whether certain officers and directors of the Company failed to properly disclose that Sequenom employees mishandled test data and results regarding the Down syndrome test.Filed by admin at April 30th, 2009 under News